2 tracked superinvestors hold BIOMARIN PHARMACEUTICAL INC (BMRN), worth $692M combined, led by Andreas Halvorsen. Smart money is accumulating BMRN as of the latest 13F filings.
Current price
$59.97
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS…
Market cap
$10.4B
P/E
30.03
Div yield
0.0%
Revenue YoY
12.9%
Analyst target
$89
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$692M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating BMRN: 1 funds added or opened versus 0 trimming.
BIOMARIN PHARMACEUTICAL INC (BMRN) is held by 2 tracked funds worth $692M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 1.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 0 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Added | 1.1% | $399M | |
| Held | 0.5% | $293M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own BMRN?
2 tracked funds hold BIOMARIN PHARMACEUTICAL INC (BMRN), the largest being Andreas Halvorsen (Viking Global Investors) at 1.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling BMRN?
In the most recent 13F quarter, 1 tracked fund added or opened BMRN and 0 trimmed it.
How much BMRN do tracked funds hold?
Combined disclosed long exposure to BMRN across tracked superinvestors is $692M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.